Currently out of the existing stock ratings of David Lewis, 159 are a BUY (52.48%), 130 are a HOLD (42.9%), 14 are a SELL (4.62%).

David Lewis

Work Performance Price Targets & Ratings Chart

Analyst David Lewis, carries an average stock price target met ratio of 84.84% that have a potential upside of 17.25% achieved within 302 days. Previously, David Lewis worked at MORGAN STANLEY.

David Lewis’s has documented 450 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ABT, Abbott Laboratories at 14-Jul-2025.

Wall Street Analyst David Lewis

Analyst best performing recommendations are on NVRO (NEVRO CORP).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 11/6/2018. The price target of $43 was fulfilled within 2 days with a profit of $4.85 (12.71%) receiving and performance score of 63.56.

Average potential price target upside

of $45.61 (25.7%) on BDX (BECTON DICKINSON AND COMPANY).
of $42.38 (33.22%) on JNJ (JOHNSON & JOHNSON).
of $33.05 (24.72%) on SWAV (SHOCKWAVE MEDICAL).

ABMD ABIOMED AXNX Axonics Modulation Technologies BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp DXCM DexCom HOLX Hologic HRC Hill-Rom Holdings IRT Independence Realty Trust ISRG Intuitive Surgical JNJ Johnson & Johnson MDT Medtronic PLC NVRO Nevro Corp PODD Insulet ZBH Zimmer Biomet Holdings EW Edwards Lifesciences Corp ABT Abbott Laboratories NARI Inari Medical SWAV Shockwave Medical HAE Haemonetics LUNG Pulmonx Corp SYK Stryker TMDX TransMedics Group NTLA Intellia Therapeutics IRTC iRhythm Technologies

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Pito Chickering (DEUTSCHE BANK)